Watching Stock Heading Into March: IBM's Turnaround in Focus
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesMarch is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
If you own rental real estate, you’ve probably wondered how to boost cash flow without waiting years for upside. A co...
Retirees should anchor planning on cash flow rather than asset size. Here is how the math stacks up in today's market...
A new income strategy built on equal weighted dividends across 54 stocks has posted 24.7% returns over the last year ...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...
Interpreting a quarterly earnings transcript can reveal a company’s true momentum. This guide shows how to read Perim...
Altria just posted strongest growth in years, signaling a potential turning point. But behind the headlines lie shift...
Schwab U.S. Dividend Equity ETF SCHD remains a cornerstone for income investors as of mid-2026, combining a low fee w...
Owlet's Q4 2025 results reveal a company balancing growth with a path toward profitability. This article disentangles...
Latin American ETFs EWZ and EWW are leading a regional rally in 2026, powered by stronger commodity markets and a shi...
If you’re hunting for reliable dividend income, AbbVie and Pfizer are two top contenders. This guide breaks down whic...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...